Holen Sie sich die Stockscreener-App
2.9467
3.53%
-0.1133
Schlusskurs vom Vortag:
$3.06
Offen:
$3.09
24-Stunden-Volumen:
2.26M
Relative Volume:
0.72
Marktkapitalisierung:
$329.89M
Einnahmen:
$1.88B
Nettoeinkommen (Verlust:
$-534.51M
KGV:
-0.5724
EPS:
-5.1483
Netto-Cashflow:
$4.76M
1W Leistung:
-6.88%
1M Leistung:
+5.80%
6M Leistung:
-67.27%
1J Leistung:
-69.06%
1-Tages-Spanne:
$2.9012
$3.14
1-Wochen-Bereich:
$2.9012
$3.16
52-Wochen-Spanne:
$2.50
$12.06
Evolent Health Inc Stock (EVH) Company Profile
Firmenname
Evolent Health Inc
Sektor
Branche
Telefon
571-389-6000
Adresse
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
2.955 | 341.61M | 1.88B | -534.51M | 4.76M | -5.1483 |
|
VEEV
Veeva Systems Inc
|
178.00 | 29.72B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
49.97 | 8.85B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
38.25 | 7.42B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
77.67 | 6.56B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.13 | 4.72B | 1.10B | 112.09M | 283.19M | 0.6096 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-25 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-11-13 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-03 | Bestätigt | BTIG Research | Buy |
| 2024-11-08 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | Hochstufung | Truist | Hold → Buy |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-01 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-10-16 | Eingeleitet | UBS | Buy |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2022-11-01 | Eingeleitet | Truist | Hold |
| 2022-07-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-11-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-04-29 | Fortgesetzt | JP Morgan | Neutral |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-07-06 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | Herabstufung | Goldman | Buy → Neutral |
| 2020-06-02 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | Fortgesetzt | Leerink Partners | Outperform |
| 2018-06-04 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-04-24 | Fortgesetzt | JP Morgan | Neutral |
| 2017-09-20 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2017-03-14 | Eingeleitet | Oppenheimer | Outperform |
| 2017-01-13 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | Fortgesetzt | JP Morgan | Overweight |
| 2016-08-05 | Bestätigt | FBR Capital | Outperform |
| 2016-07-26 | Eingeleitet | Jefferies | Buy |
| 2016-07-13 | Bestätigt | FBR Capital | Outperform |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
| 2016-01-06 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-06-30 | Eingeleitet | Goldman | Buy |
| 2015-06-30 | Eingeleitet | JP Morgan | Overweight |
| 2015-06-30 | Eingeleitet | Leerink Partners | Outperform |
| 2015-06-30 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Evolent Health Inc Aktie (EVH) Neueste Nachrichten
Investor Alert: Unprofitable Companies with High Financial Risk in 2026News and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Evolent Health downgraded at KeyBanc on EBITDA recovery concerns - MSN
Evolent Health (NYSE:EVH) Shares Cross Below 50-Day Moving AverageHere's What Happened - MarketBeat
Aug Analyst Calls: What is Evolent Health Incs 5 year growth outlookQuarterly Portfolio Review & Weekly Watchlist of Top Performers - baoquankhu1.vn
Gainers Report: How sensitive is Evolent Health Inc to inflationMarket Activity Summary & AI Forecasted Entry/Exit Points - baoquankhu1.vn
How Evolent Health Inc Class stock expands through international markets2026 Macro Impact & Verified Trade Idea Suggestions - Naître et grandir
Precision Trading with Evolent Health Inc Class A (EVH) Risk Zones - Stock Traders Daily
How The Evolent Health (EVH) Investment Story Is Shifting After Reserves Reset And Higher Leverage - Yahoo Finance
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance
Profit Recap: Is Madison Square Garden Entertainment Corp stock influenced by commodity pricesWeekly Trend Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Evolent Health (EVH) CFO awarded 429,041 performance share units tied to 2027–2029 stock goals - Stock Titan
EVH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Cowen Maintains Buy on Evolent Health (EVH) March 2026, PT Cut to $7 - Meyka
TD Cowen cuts Evolent Health stock price target to $7 on 2026 outlook - Investing.com Canada
Oppenheimer Cuts Evolent Health (NYSE:EVH) Price Target to $6.00 - MarketBeat
Evolent Health (EVH) Receives Updated Analyst Rating from Oppenh - GuruFocus
Oppenheimer Adjusts Evolent Health Price Target to $6 From $12, Maintains Outperform Rating - marketscreener.com
Evolent Health Charts Growth Amid 2026 Margin Squeeze - TipRanks
Privia Health Expands Value Based Care Scale With Evolent ACO Acquisition - Yahoo Finance
Wall Street Zen Upgrades Evolent Health Stock Rating - National Today
Evolent Health (NYSE:EVH) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Evolent Health and iRhythm Shares Are Falling, What You Need To Know - Yahoo Finance
EVH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is Evolent Health Inc affected by consumer sentimentTrade Risk Assessment & Risk Managed Investment Signals - baoquankhu1.vn
Evolent to Participate in Upcoming Investor Conferences - The Malaysian Reserve
Evolent Health price target lowered to $4 by Citigroup - National Today
EVH: Citigroup Maintains Buy Rating, Lowers Price Target | EVH S - GuruFocus
Evolent Health (NYSE:EVH) Price Target Lowered to $4.00 at Citigroup - MarketBeat
UBS Maintains Evolent Health (EVH) Rating, Lowers Price Target | - GuruFocus
UBS Group Lowers Evolent Health (NYSE:EVH) Price Target to $5.00 - MarketBeat
Privia Health Group, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Evolent Health: Cheap, Levered, But Ready To Rebound (NYSE:EVH) - Seeking Alpha
UBS Adjusts Evolent Health Price Target to $5 From $10, Maintains Buy Rating - marketscreener.com
Truist Cuts Price Target on Evolent Health to $6 From $10, Keeps Buy Rating - marketscreener.com
Privia Health (PRVA) Q4 2025 Earnings Transcript - AOL.com
Evolent Health, Inc. (NYSE:EVH) Q4 2025 Earnings Call Transcript - Insider Monkey
Evolent Health (EVH) Shares Skyrocket, What You Need To Know - Finviz
EVH Stock On Track To Open At Record Low – Here’s Why Keybanc Turned Cautious - Stocktwits
Truist cuts Evolent Health stock price target to $6 on 2026 outlook - Investing.com Australia
Evolent Health (EVH) Rating Maintained But Price Target Drastica - GuruFocus
Evolent Health (NYSE:EVH) Price Target Lowered to $4.00 at Needham & Company LLC - MarketBeat
RBC Capital Lowers Price Target for Evolent Health (EVH) by 40% - GuruFocus
Royal Bank Of Canada Cuts Evolent Health (NYSE:EVH) Price Target to $3.00 - MarketBeat
RBC Capital Adjusts Evolent Health PT to $3 From $5, Maintains Sector Perform Rating - marketscreener.com
KeyCorp Downgrades Evolent Health (NYSE:EVH) to Sector Weight - MarketBeat
BTIG Research Issues Pessimistic Forecast for Evolent Health (NYSE:EVH) Stock Price - MarketBeat
Evolent Health Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
EVH: Keybanc Downgrades Evolent Health to Sector Weight | EVH St - GuruFocus
This First Solar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
Evolent Health, Inc. SEC 10-K Report - TradingView
EVH: BTIG Lowers Price Target to $8, Maintains Buy Rating | EVH Stock News - GuruFocus
Finanzdaten der Evolent Health Inc-Aktie (EVH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.01%
0.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):